BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7519240)

  • 1. Fas and tumor necrosis factor receptor-mediated cell death: similarities and distinctions.
    Clement MV; Stamenkovic I
    J Exp Med; 1994 Aug; 180(2):557-67. PubMed ID: 7519240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis in L929 cells expressing a CD40/Fas chimeric receptor: dissociation of stimulatory from inhibitory death signalling functions.
    Rudert F; Roos M; Forbes L; Watson J
    Biochem Biophys Res Commun; 1994 Nov; 204(3):1102-10. PubMed ID: 7526859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cytotoxic CD40/p55 tumor necrosis factor receptor hybrid detects CD40 ligand on herpesvirus saimiri-transformed T cells.
    Hess S; Kurrle R; Lauffer L; Riethmüller G; Engelmann H
    Eur J Immunol; 1995 Jan; 25(1):80-6. PubMed ID: 7531151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement.
    Owen-Schaub LB; Yonehara S; Crump WL; Grimm EA
    Cell Immunol; 1992 Mar; 140(1):197-205. PubMed ID: 1371242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of malignant transformation on susceptibility of human urothelial cells to CD40-mediated apoptosis.
    Bugajska U; Georgopoulos NT; Southgate J; Johnson PW; Graber P; Gordon J; Selby PJ; Trejdosiewicz LK
    J Natl Cancer Inst; 2002 Sep; 94(18):1381-95. PubMed ID: 12237284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity.
    Hollenbaugh D; Grosmaire LS; Kullas CD; Chalupny NJ; Braesch-Andersen S; Noelle RJ; Stamenkovic I; Ledbetter JA; Aruffo A
    EMBO J; 1992 Dec; 11(12):4313-21. PubMed ID: 1385114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship of the p55 TNF receptor death domain and its lymphoproliferation mutants.
    De Wilde G; Murray-Rust J; Boone E; Olerenshaw D; McDonald NQ; Ibanez C; Haegeman G; Wollmer A; Federwisch M
    Eur J Biochem; 2001 Mar; 268(5):1382-91. PubMed ID: 11231290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD40- and HLA-DR-mediated cell death pathways share a lot of similarities but differ in their use of ADP-ribosyltransferase activities.
    Léveillé C; Zekki H; Al-Daccak R; Mourad W
    Int Immunol; 1999 May; 11(5):719-30. PubMed ID: 10330277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid CD40-mediated rescue from CD95-induced apoptosis requires TNFR-associated factor-6 and PI3K.
    Benson RJ; Hostager BS; Bishop GA
    Eur J Immunol; 2006 Sep; 36(9):2535-43. PubMed ID: 16897814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A family of ligands for the TNF receptor superfamily.
    Cosman D
    Stem Cells; 1994 Sep; 12(5):440-55. PubMed ID: 7528588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway.
    Schattner EJ; Elkon KB; Yoo DH; Tumang J; Krammer PH; Crow MK; Friedman SM
    J Exp Med; 1995 Nov; 182(5):1557-65. PubMed ID: 7595225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divergent signalling via APO-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death.
    Schulze-Osthoff K; Krammer PH; Dröge W
    EMBO J; 1994 Oct; 13(19):4587-96. PubMed ID: 7523113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the ligand binding site in Fas (CD95) by site-directed mutagenesis and comparison with TNFR and CD40.
    Starling GC; Kiener PA; Aruffo A; Bajorath J
    Biochemistry; 1998 Mar; 37(11):3723-6. PubMed ID: 9521690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD40 ligand-induced apoptosis is Fas-independent in human multiple myeloma cells.
    Tong AW; Seamour B; Chen J; Su D; Ordonez G; Frase L; Netto G; Stone MJ
    Leuk Lymphoma; 2000 Feb; 36(5-6):543-58. PubMed ID: 10784400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hetero-oligomerization between the TNF receptor superfamily members CD40, Fas and TRAILR2 modulate CD40 signalling.
    Smulski CR; Decossas M; Chekkat N; Beyrath J; Willen L; Guichard G; Lorenzetti R; Rizzi M; Eibel H; Schneider P; Fournel S
    Cell Death Dis; 2017 Feb; 8(2):e2601. PubMed ID: 28182009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome 22 complements apoptosis in Fas-and TNF-resistant mutant UK110 cells.
    Noguchi K; Naito M; Oshimura M; Mashima T; Fujita N; Yonehara S; Tsuruo T
    Oncogene; 1996 Jul; 13(1):39-46. PubMed ID: 8700552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells.
    An S; Yap D; Knox KA
    Cell Immunol; 1997 Nov; 181(2):139-52. PubMed ID: 9398401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A recessive mutant of the U937 cell line acquired resistance to anti-Fas and anti-p55 tumor necrosis factor receptor antibody-induced apoptosis.
    Noguchi K; Naito M; Kataoka S; Yonehara S; Tsuruo T
    Cell Growth Differ; 1995 Oct; 6(10):1271-7. PubMed ID: 8845304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural characteristics of CD40 ligand that determine biological function.
    Fanslow WC; Srinivasan S; Paxton R; Gibson MG; Spriggs MK; Armitage RJ
    Semin Immunol; 1994 Oct; 6(5):267-78. PubMed ID: 7532457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist antibody and Fas ligand mediate different sensitivity to death in the signaling pathways of Fas and cytoplasmic mutants.
    Thilenius AR; Braun K; Russell JH
    Eur J Immunol; 1997 May; 27(5):1108-14. PubMed ID: 9174599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.